If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRize Circular Regulatory News (CIRC)

Share Price Information for Rize Circular (CIRC)

Share Price is delayed by 15 minutes
Get Live Data
487.90    -1.475 (-0.30%)
Bid:
482.05
Ask:
487.20
Spread: 5.15 (1.068%)
Market Cap: -
CIRC Live PriceLast checked at - London Stock Exchange

Intraday Rize Circular Share Chart

Circle Holdings plc: CEO Appointment

5 Apr 2013 07:00

RNS Number : 6379B
Circle Holdings PLC
05 April 2013
 



5 April 2013

Circle Holdings PLC: CEO Appointment

The Board of Circle Holdings PLC is pleased to announce that Steve Melton has been appointed as the permanent Chief Executive Officer, effective immediately.

 

Steve assumed the role of Interim Chief Executive in December 2012, having served as Circle's Head of Mobilisation and Head of Operations respectively since joining Circle in February 2008. He has played a significant role in many of Circle's key achievements, including leading the successful opening of the Bath and Reading hospitals in March 2010 and August 2012, and the initiation and successful re-bid on the Nottingham Treatment Centre contract. He also led the final phases of bidding, negotiation, and mobilisation of the Hinchingbrooke contract.

 

Prior to Circle, Steve gained over 22 years experience of leading transformational change and business excellence programmes. Previous roles include Supply Chain Director and Head of Operational Excellence at Argos, and Supply Chain Director at Scottish Courage Ltd., where he managed over 3,000 staff and a £165m cost base. Steve was also a key leader in the ASDA turnaround team during the late 90s. He began his career on Unilever's Management Trainee Program, and held a number of roles internationally at Unilever. Steve holds an MA (First Class) in Chemical Engineering from the University of Cambridge. He is a member of the Institute of Chemical Engineers and a Fellow of the Chartered Institute of Logistics and Transport.

Commenting on the appointment, Michael Kirkwood, Circle Holdings Chairman, said: 'Steve has a strong track record of successful delivery and driving operational performance, and the Board has been impressed by the capable leadership demonstrated during his interim tenure. Under his stewardship, we have been awarded preferred bidder status on our key Nottingham contract, and improved group efficiency through an effective head office re-structure. I believe Steve has the right skills to lead Circle through the next phase of execution and growth.'

 

Steve Melton said: 'I am delighted to have been asked to lead Circle. I have long been a passionate advocate of Circle's vision and values, so relish the challenge of steering the next phase of its development. Our strength lies in our common sense approach of putting doctors and nurses in charge, and our Partnership's ability to unleash innovation that improves patient care. I am confident that this combination will produce many opportunities for Circle in the years ahead, and enable us to deliver for all our stakeholders.'

All information required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies was included in the announcement relating to Mr Steve Andrew Melton's appointment as Interim CEO, dated 4 December 2012.

 

For further information, please contact:

 

Circle Holdings PLC

Michael Kirkwood, Chairman

+44(0) 20 7034 1278

Tom Muir, Head of Communications

Numis Securities Limited

+44(0) 20 7260 1000

Michael Meade, Nominated Adviser

Alex Ham, Corporate Broking

 

About Circle

Circle Holdings' principal asset is its holding in Circle[1], an employee co-owned healthcare provider. Circle is 50.1 per cent. owned by Circle Holdings and 49.9 per cent owned by the Circle Partnership Limited which is 100 per cent beneficially owned by Circle's clinicians and employees.

Circle's objective is to redefine secondary healthcare delivery in the UK. It benefits from a unique operating model which has been successfully applied and proven, whereby clinicians are empowered to achieve high levels of patient care and efficiency, through co-ownership and active participation in managing operations. For more information see www.circlepartnership.co.uk

Circle Holdings plc is a Jersey incorporated company and the rights of shareholders may be different from the rights of shareholders in a UK incorporated company.

For more information please visit www.circleholdingsplc.com and www.circlepartnership.co.uk

[1] References to Circle in this announcement are references to Circle Health Limited.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBZLLBXZFBBBL
Date   Source Headline
21st Feb 20127:00 amRNSTrading Update
30th Jan 201211:44 amRNSNotification of Major Interest in Shares
30th Jan 201211:42 amRNSNotification of Major Interest in Shares
8th Dec 201111:56 amRNSResponse to Office of Fair Trading's Report
10th Nov 20117:00 amRNSCircle signs Hinchingbrooke contract
21st Sep 20117:00 amRNSInterim report
5th Aug 20112:16 pmRNSAppointment of Non Executive Director
6th Jul 20116:16 pmRNSHolding(s) in Company
6th Jul 20116:15 pmRNSHolding(s) in Company
6th Jul 20114:23 pmRNSBoard Appointment
4th Jul 201112:46 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
23rd Jun 20111:59 pmRNSHolding(s) in Company
22nd Jun 20119:28 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.